These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7424560)

  • 1. Prevention of experimental venous thrombosis induced by contrast medium in the rat.
    Maffei FH; Rollo HA; Fabris VE
    Acta Radiol Diagn (Stockh); 1980; 21(2A):249-52. PubMed ID: 7424560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on the antithrombotic efficacy of hirudin, heparin and a low-molecular weight heparin in preventing experimentally induced venous thrombosis.
    Monreal M; Galego G; Monreal L; Angles AM; Monasterio J; Oller B
    Haemostasis; 1993; 23(3):179-83. PubMed ID: 8276322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heparin, low molecular weight (LMW) heparin, and a heparin analogue on experimental venous thrombosis in the rabbit.
    Björck CG; Bergqvist D; Esquivel C; Nilsson B; Rudsvik Y
    Acta Chir Scand; 1984; 150(8):629-33. PubMed ID: 6085202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified crush-avulsion anastomosis model on the rat femoral vein.
    Fu K; Izquierdo R; Hubbard T; Fareed J
    Microsurgery; 1995; 16(8):536-41. PubMed ID: 8538430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A blinded trial of local recombinant tissue factor pathway inhibitor versus either local or systemic heparin in a vein bypass model.
    Rapp JH; Pan XM; Ghermay A; Gazetas P; Brady SE; Reilly LM
    J Vasc Surg; 1997 Apr; 25(4):726-9. PubMed ID: 9129630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of venous thrombosis complicating phlebography.
    Bettmann MA; Salzman EW; Rosenthal D; Clagett P; Davies G; Nebesar R; Rabinov K; Ploetz J; Skillman J
    AJR Am J Roentgenol; 1980 Jun; 134(6):1169-72. PubMed ID: 6770625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of catheter-associated thrombosis in parenteral nutrition by intravenous heparin therapy.
    Brismar B; Hårdstedt C; Jacobson S; Kager L; Malmborg AS
    Arch Surg; 1982 Sep; 117(9):1196-9. PubMed ID: 6810843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic, organic compound vepoloxamer (P-188) potentiates tissue plasminogen activator.
    Dansdill D; Halandras PM; Beverly J; Jeske W; Hoppensteadt D; Emanuele M; Fareed J; Cho JS
    J Vasc Surg; 2018 Jan; 67(1):294-299. PubMed ID: 27939143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Another method to prevent venous thrombosis in microsurgery: an in situ venous catheter.
    Hudson DA; Engelbrecht G; Duminy FJ
    Plast Reconstr Surg; 2000 Mar; 105(3):999-1003. PubMed ID: 10724260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic side-effects of lower limb venography. The use of heparin-saline flush.
    Blumgart RL; Immelman EJ; Jeffery PC; Lipinski JK
    S Afr Med J; 1991 Jan; 79(2):88-9. PubMed ID: 1989095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of postvenographic thrombosis by heparin flush: fibrinogen uptake measurements.
    Minar E; Ehringer H; Sommer G; Marosi L; Czembirek H
    AJR Am J Roentgenol; 1984 Sep; 143(3):629-32. PubMed ID: 6331748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally administered heparins prevent arterial thrombosis in a rat model.
    Pinel C; Wice SM; Hiebert LM
    Thromb Haemost; 2004 May; 91(5):919-26. PubMed ID: 15116252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and prevention of thrombosis of the subclavian vein during total parenteral nutrition.
    Fabri PJ; Mirtallo JM; Ruberg RL; Kudsk KA; Denning DA; Ellison EC; Schaffer P
    Surg Gynecol Obstet; 1982 Aug; 155(2):238-40. PubMed ID: 6808679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of single-dose antithrombotic agents in the prevention of microvascular thrombosis.
    Davidson SF; Brantley SK; Das SK
    J Hand Surg Am; 1991 Jul; 16(4):585-9. PubMed ID: 1715354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of catheter thrombosis increases survival, but does not modify lung injury in rats receiving long-term parenteral nutrition.
    Dahl PE; Karlsen BH; Kristiansen KA; Kjaeve JC
    Scand J Clin Lab Invest; 2004; 64(8):737-44. PubMed ID: 15719892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis.
    Hignett M; Spence JE; Claman P
    Hum Reprod; 1995 Dec; 10(12):3121-3. PubMed ID: 8822426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty.
    Colwell CW; Spiro TE
    Clin Orthop Relat Res; 1995 Oct; (319):215-22. PubMed ID: 7554633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat jugular vein hemostasis--a new model for testing antithrombotic agents.
    Raake W; Elling H
    Thromb Res; 1989 Jan; 53(1):73-7. PubMed ID: 2538004
    [No Abstract]   [Full Text] [Related]  

  • 20. The heparin flush: an aid in preventing post-venography thrombophlebitis.
    Arndt RD; Grollman JH; Gomes AS; Bos CJ
    Radiology; 1979 Jan; 130(1):249-50. PubMed ID: 758661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.